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ABSTRACT
Tephrosia purpurea is a species of flowering plant in the pea family, 
Fabaceae, widespread in the Indian subcontinent. In Unani system of 
medicine it is either used as a single drug or as an ingredient in many 
Unani formulations which are use in the treatment of various ailments 
of the body. In the present manuscript the information available about 
this drug in Unani literature, phytochemical and pharmacological 
investigations carried out upto August 2018 are summarized. Sarphuka 
is a blood purifier, diuretic, digestive, laxative, resolvent, antidote etc. 
It is used in the treatment of syphilis, gonorrhea, leprosy, pruritus, 
inflammation, hemorrhoids and skin diseases. Pharmacological and 
clinical investigation of Tephrosia purpurea revealed anti-inflammatory, 
analgesic, hepatoprotective, immunomodulatory anti-diabetic, anti-
bacterial, antioxidant, antileishmanial, anti-carcinogenic and anti-
lipidperoxidative activities. 
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INTRODUCTION
Unani System of Medicine is a complete medical 
system which offers promotive, preventive and 
curative healthcare since antiquity. This is based on 
medical substances derived from plants, animals 
and minerals. More than one thousand drugs are 
described in alphabetic manner in the text of Advia 
(pharmacology) from all the three natural sources. 
Based on their origin, the Unani drugs are classified 
into three categories: Drugs of plant origin includ-
ing root, stem, bark, leaves, flower, seed, fruit, gum, 
resin, extract etc. Drugs of mineral origin including 
metals; metal ores and nonmetals in the natural 
form, while animal origin drugs are animal glands, 
tissues and certain animal poisons.1 Plant origin 
drugs are the backbone of Unani pharmacotherapy. 
Tephrosia purpurea Linn.(T. purpurea) is a well-
known plant described in the ancient text of Unani 
meaning "ash-colored," referring to the grayish tint 
given to the leaves. It belongs to high medicinally 
valued plant family Fabaceae, comprising of more 
than 400 species. It is found throughout India and 
Sri Lanka flourishing in poor soil, through the 
plains of India, Ceylon, Mauritius, Tropical Africa 
and subtropical regions.2
Tephrosia species have historically been used 
by indigenous cultures as fish toxins because of 
their high concentration of rotenone. It has a long 
history of its use as an important drug for the treat-
ment of syphilis, gonorrhea, leprosy and various 
skin diseases. Its roots, leaves, seeds and stem bark 
are traditionally used as folk medicine. In Ayurveda 
T. purpurea is considered as digestible, anthelmi-
nitic, alexiteric, antipyretic and alternative. It cures 
diseases of liver spleen, heart, blood, asthma and in 
mild poisoning. Leaf extract is used to treat piles, 
bronchitis, boils and pimples. Roots and seeds are 
insecticidal. Ointment prepared from the root is 
used in elephantiasis’. The oil from seeds is said to 
be specific against scabies, itch, eczema and other 
eruption on the skin. Leaves are used as a fodder 
also. Seeds can be used as substitute of coffee.3
The drugs in Unani system of medicine are cate-
gorized according to their actions e.g. tonic, aphro-
disiac, purgatives, concoctive, exhilarants, blood 
purifiers etc. T. purpurea comes under the category 
of blood purifier.4,5 The scrutiny of Unani literature 
revealed that Sarphuka is an efficient drug used in 
various dosage forms for the treatment of skin and 
other disorders associated with morbid blood. It is 
also used as an important ingredient in blood puri-
fier formulations.6
Due to the unorganized literature available on 
this important drug an effort has been made in the 
present paper to compile all the available infor-
mation which reveals the therapeutic potential of 
this multi potent drug. The aim is to explore the 
properties mentioned in Unani and ethno botanical 
literature and emphasize its phyto pharmacological 
attribute.
METHODOLOGY
A bibliographic search was carried out to 
collect the available information on T. purpurea. 
Contemporary reference books, relevant arti-
cles, periodicals, peer reviewed indexed journals 
and other published works available on Pub 
Med, Science Direct, and Scopus were searched 
to retrieve online literature. The search was 
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conducted using the terms “Sarphuka” ‘Tephrosia 
purpurea’, ‘studies on Tephrosia purpurea, 
‘review on Tephrosia purpurea”. Further books, 
monographs and reports on Tephrosia purpurea 
published in Urdu and English were used to 
compile the information. Standard Unani Medical 
Terminology published by Central Council for 
Research in Unani Medicine in collaboration with 
World Health Organization was used to describe 
the appropriate Unani terminologies. Plant names 
cited throughout manuscript were checked for 
the currently accepted valid names through www.
theplantlist.org. The full text of each included arti-
cle was critically reviewed, and valuable informa-
tion was summarized.
VERNACULAR NAMES7
Bengali :  Bannilgachh, Sarphonka, purple 
tephrosia, fish poison
English : Wild Indigo
Gujrati :  Ghodakan, Jhila, Sarpankho, 
Sharpankho
Hindi :  Sarphoka, Sarphonka, Dhamasia
Kannada :  Empali, Vajaraneeli, Koggili
Malyalam :  Kolinnil, Kozhenjil, Kaatamiri
Oriya :  Kolothiyapokha, 
Mohisiakolothiga, Pokha, 
Soropokha
Punjabi :  Bansa, Bansu, Jhojhru, Sarpankh, 
Sarphonka
Sanskrit  
:
 Banapunkha, Ishupunkhika, 
Kalashaka, Kalika, Sharapunkha
Tamil :  Kolingi, Paavali, Katkolingi, 
Kolluk-kay-velu
Urdu : Sarabhuka
BOTANICAL DESCRIPTION
Macroscopic features 
T. purpurea is a perennials, erect or decumbent 
herbs or sub shrubs, height ranges from 50 cm to 
1.5 meter. Compound leaves imparipinnate; termi-
nal leaflets 7-15, 1-2.8 x 0.3-1 cm, oblanceolate or 
obovate, base cuneate, apex obtuse toemarginate. 
Flowers 7 mm long, purplish to white, bisexual, 
symmetrically, zygomorphic, hypogynous. In 
few-flowered, leaf is opposed, pseudoracemes; 
pedicels 3-4 mm long; bracts, 2 mm long, calyx, 
3-4  mm long. Corolla, pink to purplish; 4 mm 
broad, orbicular and staminal tube, 4 mm long. Pod 
is dry dehiscent 2.5-4 x 0.3-0.4 cm, linear-oblong, 
5-7-seeded. Seeds are ellipsoid, dark brown in 
colour.8
Microscopy
Study of stomatal index shows a range of 11-24 
adaxial surface and 6-16 abaxial surface.Study 
shows that its leaves have vein-islet number within 
the range of 14-29 with non glandular, simple, 
elongated and aseptate trichomes, crystal sheath 
surrounding the large vascular bundle which are 
capped by fiber strands on both adaxial and abaxial 
side and presence of collenchyma cells on the upper 
ridge of the midrib.9 
ETHNOMEDICINAL USES 
T. purpurea is reported to be useful in kidney 
disorders and cough. In Bundelkhand region the 
folk men use the smoke of its root powder for 
the treatment of asthma and cough. An extract of 
pods is given as a cure for pain and inflammation. 
Their decoction is used to stop vomiting and as 
a vermifuge.10 The dried herb is effective as an 
energizer, laxative and diuretic. It is also used in 
the treatment of bronchitis, bilious febrile attack, 
boils, acne, diseases of teeth, scrofula, painful 
labor and hemorrhoids. The roots and seeds are 
reported to have insecticidal, pesticidal, and 
vermifugal properties. Leaves are prescribed in 
dyspepsia, pectoral diseases and hemorrhoids, 
etc.11 The roots are effective in leprous wounds and 
the root juice is useful in skin eruptions. Seeds, 
roots and ash are useful traditionally and also 
cultivated as fertilizer.12 For rodent bites, the seed 
powder of T. purpurea is used with butter milk to 
treat poisoning.13 
DESCRIPTION OF SARPHUKA IN UNANI 
LITERATURE
Morphological characteristics
The morphological characteristics of Sarphuka in 
Unani literature is not as efficient as needed for its 
identification. However, some of the key features 
are described by Unani physicians, on the basis of 
that description Sarphuka is identified as the plant 
of T. purpurea Linn. According to Unani literature, 
Sarphuka is an Indian origin plant, half meter long, 
stem is thin has many branches, leaves are arranged in 
parallel manner. It bears flowers and legumes. Its two 
types are mentioned on the basis of the color of flower. 
One has white and other has red flowers. The plants 
bearing white flowers are rare. Seeds are small kidney 
shaped, four to five seeds are found in a single pod. 
Taste of whole plant is bitter and unpleasant.4,14,15,16,17 
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Properties 
Temperament
Like all entities of the Universe, Drugs are also 
constituted by the mixing of elements, therefore, 
their basic character is indicated by the resulting 
qualitative temperament. Mizaj (temperament) is 
one of the basic concepts of Unani system of medi-
cine. The Mizaj of drugs have been articulated in 
terms of four kaifiyat (qualities) viz. har (hot), barid 
(cold), yabis (dry) and ratab (moist).18,19 The degree 
of mizaj depends upon the relative proportion 
of these four kaifiyat and the drugs of particular 
temperament are categorized accordingly. When it 
is said that a drug is hot or cold, it does not mean 
that it is intrinsically very hot or cold, or that it is 
hotter or colder than the human body. Rather, it 
indicates that such a drug produces a greater degree 
of heat or cold in the body than what was origi-
nally present. Further, the same drug may be less 
hot for one person than for the other. This is one 
of the reasons why different drugs are prescribed 
for the same disease in different persons.20 The 
temperament of Sarphuka is hot and wet in first 
degree.4,15,16,17 According to the book Ilmul advia 
Nafisi temperament of Sarphuka is hot and dry in 
first degree.14
Pharmacological actions4,14,15,16,17
A few references regarding its pharmacological 
properties are available in Unani text. It is cited to 
have blood purifier, diuretic, antidote, anthelmintic, 
antipyretic, tonic, laxative, deobstruent, digestive, 
euphoretic and antileprotic properties.
Mechanism of action4,14,15,16,17
T. purpurea is one such drug which is listed in the 
blood purifier group of drugs. It has the property 
to purify blood from toxic substances by various 
mechanisms. Since its taste is bitter and temper-
ament is hot therefore it has a number of phar-
macological properties viz. demulcent, laxative, 
resolvent, deobstruent, diuretic, antiseptic etc. By 
virtue of these characteristics it is able to transform 
the morbid viscous matter into such a form which 
can be easily evacuated by the body. Since it has 
laxative and diuretic property therefore morbid 
matters are removed by respective organs. It also 
has the property to tone up the function of sluggish 
liver, kidney and stomach, in this way it does not 
only cure the disease but also prevent it by normal-
izing the performance of all these organs.
Therapeutic uses4,5,14,15,16,17 
In the light of above mechanism of action, 
T.  purpurea is used in the treatment of all those 
diseases which are caused by impure/morbid blood 
such as acne, ulcer, itching, leprosy, syphilis, fever, 
inflammation and numerous skin disorders as well 
as venereal diseases. Since each part of T. purpurea 
has medicinal properties therefore either whole 
plant or its part are used in the treatment of vari-
ous disorders e.g. Tender leaves have good results 
in treating eczema and vitiligo or patchy skin. It is 
also used to reduce blood toxicity caused by heavy 
metallic drugs or bhasma. Apart from skin diseases 
Sarphuka is also used in various other ailments of 
the body. For this purpose, it is either used orally in 
various dosage forms viz. powder, syrup, decoction, 
extract, tablet etc. or locally as paste and ointment. Its 
root is diuretic, allays thirst and enriches blood. The 
dried herb is given for the treatment of bronchitis, 
bilious febrile attacks, boils, pimples and bleeding 
piles. The leaf decoction is used for treating fever, 
heart and spleen disorders, digestive complaints, 
asthma and cancerous tumors. The extract of leaf 
is used in the management of abortion, quaternary 
and tertiary fever. Apart from single and compound 
formulations, Sarphuka is also combined with other 
drugs viz.100 gm of crushed leaves of Sarphuka 
and 50gm of cannabis leaves (Cannabis sativa 
Linn.) are mixed together, from which 4-6 gm if 
taken regularly for forty days cures piles. Tablet 
made from black pepper (Piper nigrum) and fresh 
root of Sarphuka, is used to reduce chronic gastric 
problems. If the paste of black pepper (5gm) and 
Sarphuka (7gm) applied locally reduces the inflam-
mation of breast. Juice of Sarphuka with dry ginger 
(Zingiber officinale Roscoe.) provides relief from 
irritable bowel syndrome and with clove (Syzygium 
aromaticum) powder relieves chronic diarrhoea. 
If used in combination with baubadang (Embelia 
ribes), is very useful in expelling intestinal worms. 
Leaves juice is effective in leprosy. It relieves consti-
pation and effective in spleenomegaly.
Toxicity
It is common belief that Unani drugs are safe but 
the fact is that the drug will not be a drug if it does 
not produce any side effect or unwanted effect. 
For this purpose Unani drugs are categorised into 
four degrees and mostly first and second degree 
drugs are found safe if used for short period but 
third and fourth degree drugs are not free from 
toxic effect therefore they are detoxified by some 
corrective procedures.21 Unani physicians have not 
discussed any toxic effect of T. purpurea, however 
some of the physicians reported that it causes 
eructation.4,5,14,15,16,17
Correctives
Sarphuka is listed in the first category hence it does 
not need any corrective procedure however Unani 
system of medicine has a unique specialty of adding 
Corrective Drugs (Muslih Adwiya) to counter the 
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toxicity/undesirable effect of the main drug if 
any.  Brahmadandi (Tricholepis glaberrima DC) is 
suggested as corrective drug for Sarphuka. 
Substitutes
Amongst the various aspects of basic principles 
of drugs, Abdale-e-Advia, (substitution of drugs) 
is one of the most important principles, which 
governs the rules relating to drug substitution. 
Classical Unani literature has fully discussed about 
substitutes of almost all single drugs used in Unani 
System of Medicine22 because all crude drugs are 
not available at all the times and everywhere.22,23 
The substitute of Sarphuka is suggested by Unani 
physicians are Mundi (Sphaeranthus Indicus) or 
Neelkanthi (Ajuga bracteosa).4,14,15,16,17 
Compound formulations
Unani System of Medicine prescribes elaborate 
formulation or pharmaceutical processing of drugs 
for achieving stability, palatability, absorption 
and assimilability, and for enhancing efficacy and 
safety. The compound preparations of Sarphuka 
are Sharbate musaffi, Safoof juzam, Arq maul jubn, 
Arq murakkab musaffie khun banushka kala. These 
formulations contain blood purifier drugs with 
Sarphuka as one of the ingredients, prescribed 
widely with other musaffie dam (blood purifier) 
formulations in the management of skin diseases. 
These formulations especially arqiyat (distillate) 
are used to catalyze or enhance the efficacy of other 
musaffie dam preparation.4,14,15,16,17
PHYTOCHEMISTRY
Phytochemical screening of the plant discov-
ered numerous compounds such as presence of 
rotenoids, isoflavones, flavanones, chalcones, 
sterols, flavonols, flavones, alkaloids, steroids, 
rutin and rotenoids, oil as well as fatty acids. Other 
compounds like quercetin were also isolated from 
T. purpurea. The immense range of structure is 
due to variation in the position of hydroxy substit-
uents or isoprenyl substituents. Seeds contain 
karanjin, purpurin24 pongamol , lanceolatin B , 
purpuritenin, and purpuretimethide25 etc. Very 
few chalcones were reported in this genus. They 
are either furano or chromano chalcones with 
un substituted B ring. Roots contain flavonoids, 
apollinine, semiglabrin, semiglabrinol, tephrogla-
brin, tepurindiol, pongamol, iso-lonchocarpin, 
O-methylpongamol, lanceolatins A and B etc. 
Leaves contain a flavonoid: rutin, a triterpenoid: 
lupeol, and a sterol: β-sitosterol, etc. The whole 
plant contains the flavonoids (+)-tephrorins 
A and B and (+)-tephrosone26 an isoflavone 7, 
4-dihydroxy-3’, 5’-dimethoxyisoflavone and a chal-
cone (+)-tephropurpurin.27
Reinvestigation of the extract of aerial parts 
of T. purpurea resulted in the isolation and struc-
tural elucidation of three compounds, namely an 
aromatic ester, a sesquiterpene of the rare rotun-
dane skeleton and a prenylated flavonoid isolated 
for the first time from this species.28 
PHARMACOLOGICAL ACTIVITY
Nephroprotective and anti lithiatic activity
Alcoholic extract of T. purpurea revealed nephro-
protective activity in gentamicin-induced kidney 
cell damage and in vitro hydroxyl radical scaveng-
ing activity.29 A research was conducted on the 
chemopreventive efficacy of T.purpurea against 
N-diethylnitrosamine-initiated and potassium 
bromate-mediated oxidative stress and toxicity in 
rat kidney. The result indicates that T. purpurea 
is a potent chemopreventive agent against renal 
oxidative stress and carcinogenesis induced by 
N-diethylnitrosamine and KBrO3by reducing lipid 
peroxidation and xanthine oxidase activities and 
enhancing antioxidant enzyme activity.30
Antiulcer activity
Antiulcer activity of T. purpurea extract was studied 
in rats in which gastric ulcers were induced by oral 
administration of ethanol, or 0.6 mol·L−1 HCl, or 
indomethacin, or by pyloric ligation, and duode-
nal ulcers were induced by oral administration of 
cysteamine HCl. Omeprazole was used as a refer-
ence drug. The ulcer index in the T. purpurea-treated 
animals was found to be significantly less in all the 
models compared to vehicle control animals. The 
antiulcer property was more prominent in animals 
in which ulcers were induced by HCl, indometha-
cin, and by pyloric ligation. Omeprazole produced 
a significant gastric and duodenal ulcer protective 
effect when compared with the control group. The 
anti-ulcer activity of T. purpurea was however, 
less than that of omeprazole. Results suggest that 
T. purpurea possesses significant antiulcer prop-
erty which could be either due to cyto-protective 
action or by strengthening of gastric and duodenal 
mucosa, and thus enhancing mucosal defense.31 
The aqueous root extracts of T. purpurea (100 and 
200mg·kg−1) were screened for ulcerative colitis 
using the method of acetic acid-induced ulcerative 
colitis in mice. Macroscopical study of the colon, 
level of myeloperoxidase in colon, and histopathol-
ogy of the colon tissue was studied for the assess-
ment of activity. Results showed that the aqueous 
extract was effective in the treatment of ulcerative 
colitis at adose of 200 mg·kg−1.32
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Spasmolytic, bronchodilator and 
vasorelaxant activity
Soni et al., (2004) performed the experiment for 
spasmolytic activity from leaves on isolated tracheal 
tissue of guinea pig. The effect of alcoholic and water 
extract of T. purpurea was dose dependent and the 
action was prolonged with increase in dose.33 The 
methanolic extract of the whole plant of T. pupurea, 
Linn. on application to spontaneous contractions 
in isolated rabbit jejunum preparations exerted a 
concentration dependent(0.003-3.0 mg/mL) relax-
ant effect. The extract also caused concentration 
dependent relaxation of K+ (80 mM)-induced 
spastic contractions. These findings were further 
supported by the observations that the extract 
caused a concentration dependent right ward shift 
of the Ca2+ response curves in manner similar to 
that of verapamil. The extract exhibited a relaxant 
effect on carbachol and high K+ (80 mM)-induced 
contractions of isolated rabbit tracheal preparations 
in a manner similar to verapamil. The observed 
non-specific bronchodilator response is possi-
bly mediated through Ca2+ channel blockade. 
Moreover, the extract also exhibited a dose depen-
dent relaxant effect on phenylephrine (1 μM) and 
K+ (80 mM)-induced contractions in a manner 
similar to verapamil.34 
Antileishmanial Activity
A fraction (F062) obtained from N‐butanol extract 
of  T. purpurea  showed consistent antileishmanial 
activity at 50 mg/ kg against  Leishmania dono-
vani  infection in hamsters. Activity was further 
confirmed in a secondary model, i.e., Indian langur 
monkeys (Presbytis entellus). Thus, the fraction 
F062 from this plant possesses potential to produce 
significant antileishmanial activity by oral route 
without producing any toxic effect.35 
Antidiabetic activity
Studies revealed that an aqueous seed extract of 
T. purpurea resulted in a decrease in the blood 
glucose concentration, and also increased insu-
lin level, which could be due to the stimulation 
of insulin secretion from remnant pancreatic 
β-cells which in turn enhance glucose utilization 
by peripheral tissues. Antioxidant status was 
observed in streptozotocin-induced diabetic rats. 
There is decreased hemoglobin and increased 
glycosylated hemoglobin levels in diabetic 
rats. Increased hemoglobin in T. purpurea-
treated diabetic rats indicated decreased blood 
glucose level and glycosylated hemoglobin. 
Oral administration of T. purpurea to diabetic 
animals significantly improved hexokinase and 
glucose-6-phosphatase activities.36
Another study reported that T. purpurea seeds 
possess membrane stabilizing effect in streptozo-
tocin induced diabetic male Wistar rats probably 
due to the presence of flavonoids and isoflavonoids 
which could be responsible for its anti-lipid peroxi-
dative and insulin stimulatory effects.37
Antioxidant activity
Antioxidant activity of ethanol extract and ethyl 
extract of T. purpurea were tested for CCl4–
induced lipid peroxidation and superoxide gener-
ation. Results indicate that ethyl acetate extract 
has pronounced antioxidant effect as compared to 
ethanol extract. The effects of tannins and flavo-
noids can be largely attributed to their antioxidant 
properties.38
Antiepileptic Activity
Investigation revealed the anti-epileptic action of 
T. purpurea in status epilepticus induced in rats by 
pilocarpine administration after lithium chloride. 
The results of the lithium- Pilocarpine-induced 
status epilepticus model confirmed that the ethan-
olic extract of T. purpurea has significant ability in 
treating the severity of status epilepticus.39
In one more study, aqueous extract of T. purpurea 
root showed antilithiatic effect by reducing the 
formation of stone and dissolving existing, calcium 
oxalate (gentamicin and 5% ammonium oxalate) 
and magnesium ammonium phosphate stones 
(zinc discs).40
Wound healing activity
Wound healing potential of different root extracts 
of T. purpurea was assessed by excision, incision 
and dead space wound models in rats. The result 
demonstrated that methanolic extract have a defi-
nite pro healing action. This was confirmed by a 
significant increase in the rate of wound contraction 
and by enhanced epithelization. Significant increase 
in tensile strength and collagen levels were seen, 
which was further supported by histopathological 
studies and gain in granuloma breaking strength.41 
In another study ethanolic extract of T. purpurea 
(aerial part) in the form of simple ointment  were 
used on three types of wound models in rats as 
incision wound, excision wound and dead space 
wound.  The results were compared to standard drug 
Fluticasone propionate ointment, in terms of wound 
contraction, tensile strength, histopathological and 
biochemical parameters such as hydroxyproline 
content, protein level, etc. Histopathological study 
showed significant (P<0.05) increase in fibroblast 
cells, collagen fibres and blood vessels formation. 
All parameters were observed significant (P<0.05) 
in comparison to control group.42
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Antiviral activity
The methanol extract of T. purpurea flowers was 
studied for antiviral activity by using various 
virus cultures viz., HeLa cell cultures, HEL cell 
cultures and Vero cell cultures. The results showed 
good antiviral activity of the flower extract of 
T. purpurea.43
Hepatoprotective activity 
The ethyl acetate fraction of an ethanol extract 
of the roots of T. purpurea was investigated for 
its hepatoprotective activity in rats by inducing 
hepatotoxicity with CCl4. The results showed that 
oral administration of T. Purpurea resulted in a 
significant reduction in aspartate aminotransferase, 
alanine transaminase, alkaline phosphatase and 
total bilirubin, when compared with CCl4-damaged 
rats. A comparative histopathological study of liver 
from the test group exhibited almost normal archi-
tecture, as compared to the CCl4-treated group. 
Hepatoprotective activity of T. purpurea exhib-
ited better effectiveness than Silymarin in certain 
parameters.44
In other study Twenty four wistar albino rats 
of either sex were randomly divided into three 
groups. Group II and III were orally administered 
with sodium arsenite (10 mg/kg) daily in drinking 
water for 28 days. Additionally Group III was orally 
treated with hydro-alcoholic extract of T. purpurea  
at 500 mg/kg daily for the same time period, while 
only deionized water was given to Group I (control). 
Results revealed that T. purpurea significantly (P < 
0.01) reduced serum ALT, AST, ALP activity and 
increased total protein and reduced necrosis and 
inflammation in liver of group III compared to 
group II.45 
Aqueous-ethanolic extract of aerial parts of 
T.  purpurea (100, 300 and 500 mg/kg/day and 
ethanolic extract of stem bark of Tecomella undu-
lata (200, 500 and 1000 mg/kg/day were studied 
for their hepatoprotective effects. Hepatotoxicity 
was induced in albino rats of either sex by subcu-
taneous injection of thioacetamide. Test drugs 
shoewed significant reduction in serum aspartate 
aminotransaminase (35% and 31%, respectively), 
alanine aminotransaminase (50% and 42%, respec-
tively), gamma glutamyl transpeptidase (56% and 
49%, respectively), alkaline phosphatase (46% 
and 37%, respectively), total bilirubin (61% and 
48%, respectively) and liver MDA levels (65% and 
50%, respectively), and significant improvement 
in liver glutathione (73% and 68%, respectively) 
when compared with thioacetamide damaged rats. 
Histology of the liver sections of the animals treated 
with the extracts also showed dose-dependent 
reduction of necrosis.46
Analgesic and Anti-inflammatory activity
Analgesic activity of T. purpurea was carried out using 
acetic acid-induced writhing in mice and the tail 
flick test in rats. The anti-inflammatory activity was 
estimated using carrageenan-induced rat paw edema 
and cotton pellet granuloma formulation in rats. 
T. purpurea were found to be more effective in prevent-
ing carrageenan-induced rat paw edema, cotton pellet 
granuloma formation, and acetic acid-induced rat 
paw edema.47 Anbarsi and Vidya, (2015) reported that 
anti inflammatory activity of T. purpurea seeds extract 
is due to presence of several bioactive compounds 
such as flavonoids and triterpenoids.48
Antimicrobial activity
The isolated saponin was tested for its antimicrobial 
activity. Maximum inhibition was recorded against 
the Gram-positive bacterium Streptococcus pneu-
moniae, and complete inhibition was observed on 
the growth of the fungus Alternaria alternata.49 
In other study, the petroleum ether, alcoholic and 
aqueous extract of seeds of T.purpurea were found 
to have antibacterial activity against Bacillus subti-
lis, Escherichia coli and Pseudomonas aeruginosa.50
Anxiolytic activity
Hydroalcoholic extract of T .purpurea was studied 
in mice using the elevated plus-maze, zero-maze, 
y-maze, and hole-board models. In addition, the 
anxiolytic effects of the hydroalcoholic extract at 
the dose 200 and 400 mg·kg−1 orally was compared 
with diazepam. extract was able to increase the time 
spent and the number of arm entries in the open 
arms of the elevated plus-maze and elevated zero-
maze, as well as decrease the visits by mice in the 
Y-maze, it also significantly increased nose poking, 
line crossing, and rearing in the hole-board assay. 
This effect was comparable to that of the diazepam, 
indicating that the extract of T. purpurea is an effec-
tive anxiolytic agent.51
Mast cell stabilizing potential (anti allergic) 
activity
An extract of the aerial part of T. purpurea was 
studied for the mast cell stabilizing potential against 
clonidine-induced mast cell degranulation, in adult 
Wistar rats. The result revealed that the ethanolic 
extract has dose-dependent, significant reduction 
in mast cell degranulation as compared to the clon-
idine-treated animals; however its effect was less 
than dexomethasone and disodium cromoglycate, 
which are potent mass cell stabilizers.52
Cytotoxic activity
The chloroform extract of the powdered root of 
T. purpurea was used for preliminary chemical 
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screening, and brine shrimp hatch ability and lethal-
ity testing. The inquiry was extrapolated to animal 
cell lines, Daltons lymphoma ascities and Erhlich 
ascites carcinoma. The Trypan blue exclusion method 
was used for this screening and confirmed the potent 
cytotoxic activity of T. purpurea.53 The chemopre-
ventive potential of T. purpurea extract was assessed 
in N-nitrosodiethylamine-induced hepatocellula 
rcarcinoma in Wistar rats. Hepatocellular carcinoma 
was induced by a single intraperitoneal injection of 
N-nitrosodiethylamine (200 mg·kg−1) followed by 
subcutaneous injections of CCl4 (3  mL·kg−1 per 
week) for six weeks. T. purpurea extract were admin-
istered orally once a day throughout the study. The 
levels of liver cancer markers, including  α-fetoprotein 
and carcinoembryonic antigen, were substantially 
increased by N-nitrosodiethylamine treatment. 
T.  purpurea extract treatment significantly reduced 
liver injury and restored the entire liver cancer 
markers. Additionally the extract normalized the 
activity of antioxidant enzymes, namely lipid perox-
idation, reduced glutathione, catalase, superoxide 
dismutase, glutathione peroxidase, and glutathione-
S- transferase in the liver of N-nitrosodiethylamine 
treated rats.54 
Treatment with T. purpurea significantly reduced 
the nodule incidence and multiplicity in the carcin-
ogen-bearing rats. Histological observations of the 
liver tissues correlated with the biochemical obser-
vations. Cytotoxic activity of different fractions of 
T. purpurea was tested in the human MCF-7 cancer 
cell line by trypan blue exclusion method. Two frac-
tions of T. purpurea showed IC50 values of 152.4 
and 158.71 μmol·L−1.55 
According to Muralidhar et al., (2014), aqueous 
and ethanolic extracts of roots of this plant showed 
potential anticancer activity against Ehrlich ascites 
carcinoma cells in Swiss albino mice.56
Antimalarial activity
The extract of T. purpurea proved antiplasmodial 
activity against the D6 (chloroquine-sensitive) and 
W2 (chloroquine-resistant) strains of Plasmodium 
falciparum with IC50 values of (10.47 ± 2.22) 
and (12.06 ± 2.54) μg·mL−1, respectively. A new 
prenylated flavone, terpurinflavone, isolated from 
T. purpurea extract illustrated antiplasmodial activ-
ity with IC50 values of (3.12 ± 0.28) μmol·L−1 (D6) 
and (6.26 ± 2.66) μmol·L−1 (W2).57
Atilaw et al.,(2017), isolated four new prenylfla-
vones with seven known compounds from the stem 
of T. purpurea subsp. leptostachya. The isolated 
flavones were tested for antiplasmodial activity 
against the D6 strain of Plasmodium falciparum. 
Among these, (E)-5-hydroxytephrostachin (1) 
showed good activity (IC50 1.7 _M).58
Anti pyretic activity
The methanolic extract of whole plant of T. purpurea 
at a dose of 250mg/kg and 500mg/kg body weight 
were investigated for antipyretic activity. The meth-
anolic extracts showed potential significant anti-
pyretic activity from 1 hour onwards as compared 
to the standard drug paracetamol amongst various 
extracts. The significant antipyretic activity may be 
due to the presence of flavonoids.59
CNS depressant and analgesic activity
Investigation of CNS depressant and analgesic 
activities of ethanol, ethyl acetate, chloroform and 
petroleum ether extracts of T. purpurea root using 
actophotometer for CNS depressant activity and 
analgesic activity using tail immersion method in 
albino rats of both sexes. The result showed that all 
the extracts were found to possess CNS depressant 
and analgesic activities. Ethanol extract showed 
higher CNS depressant activity and possessed 
approximately similar analgesic activity as that of 
diclofenac sodium after 120 minutes.60 
Anti hyperlipidemic activity
The anti hyperlipidemic activity of ethanolic extract 
of T. purpurea at dose of 400 and 800 mg/kg b.w. 
was found to be significant as indicated by decrease 
in total cholesterol level of rats when compared to 
hyperlipidemic control.61
Anthelmintic activity
The various concentrations of aqueous and methan-
olic extract of leaves were evaluated for anthelmintic 
activities on Pheretima posthuma. The methanolic 
leaf extract not only showed paralysis but death of 
the organism with increasing concentration.62
CONCLUSION
On the basis of available literature it is concluded 
that Sarphuka is a drug used in Unani and other 
traditional system of medicine for the treatment 
of various ailments of the body. It is a multi potent 
drug though its major use in the treatment of skin 
diseases due to its blood purifying activity is also 
found effective in many other health problems. 
A number of research studies viz. hepatoprotec-
tive, diuretic, analgesic, antifungal, antioxidant, 
anti-inflammatory, and antibacterial, antipyretic, 
wound-healing are testimony of its potentials. 
Interestingly, most of the properties, which are 
claimed by Unani physicians, are verified by phar-
macological studies. However, all these studies are 
preliminary in nature; no study is conducted on 
skin diseases and safety profile is also not estab-
lished yet. Therefore, a detailed toxicity, animal 
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and clinical study is needed in general and in skin 
diseases in particular so that its safety, efficacy and 
exact mechanism of action can be established. 
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